Stay updated on NC410 Plus Pembrolizumab Clinical Trial
Sign up to get notified when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.

Latest updates to the NC410 Plus Pembrolizumab Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedThe history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This is a metadata update with no impact on the study information.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedVersion updates show termination after Phase 1b and the posting of results for the NC410 plus Pembrolizumab trial. The history also adds updates to the study status and includes Outcome Measures in the results section.SummaryDifference0.9%

- Check35 days agoChange DetectedThe study record's change history adds a new revision entry v3.6.5; the previous revision v3.6.4 is listed under deletions, signaling an update to the version history.SummaryDifference0.1%

- Check49 days agoChange DetectedThe page shows a new revision (v3.6.4) that supersedes the previous version (v3.6.3), indicating an updated page revision.SummaryDifference0.1%

- Check56 days agoChange DetectedA new version entry on 2026-07-15 adds core study sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and related areas (Oversight, Study Status, Recruitment Status) to the record. The update also introduces a Quality Control status (Has Not Concluded) and navigation items such as More Information and Document Section.SummaryDifference1%

- Check71 days agoChange DetectedA new revision entry (v3.6.3) was added to the history, replacing the previous v3.6.2 and signaling an update to the record's documentation.SummaryDifference0.1%

Stay in the know with updates to NC410 Plus Pembrolizumab Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NC410 Plus Pembrolizumab Clinical Trial page.